A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia

NCT01142011 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Symptomatic Waldenstroms Macroglobulinaemia

Interventions

DRUG: Belimumab

Sponsor

Cancer Trials Australia

Collaborators

[object Object]